Davita clinical research study indicates effectiveness of mrna covid-19 vaccines in dialysis patients

Denver, nov. 29, 2021 /prnewswire/ -- dialysis patients who received mrna covid-19 vaccines had a lower risk of covid-19 diagnosis post-vaccination and were less likely to be hospitalized or die following breakthrough infection than unvaccinated patients, according to a davita clinical research (dcr) study published online ahead of print by the journal of the american society of nephrology. "this is the first large study aimed at understanding the clinical effectiveness of covid-19 vaccines in this highly vulnerable patient population," said dr. steven brunelli, mcse, vice president for dcr.
DVA Ratings Summary
DVA Quant Ranking